Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Find out Where To Position Dividend Aristocrats Etf In Portfolio to optimize diversification, risk, and income potential within a blended strategy.
18,597 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
The chatter around prediction markets booming is loud, but this guide helps you focus on three AI stocks with real up...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
Nvidia just increased holding in a high-growth AI stock that has climbed nearly 50% this year. This article breaks do...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...
SpaceX remains a private giant with sky-high growth prospects. If spacex stock: dip? ever becomes a reality, investor...
Bitcoin has skyrocketed from a fringe project to a multi-trillion-dollar asset, while gold remains the timeless store...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...
When a CEO optimizes liquidity by selling shares, it sparks questions. This guide dives into xometry's (xmtr) recentl...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
A bold forecast from Nvidia's founder centers on an AI spending boom. This article breaks down the rationale, the mat...
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...